ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
Double blind RCT aiming to compare the efficacy of Anakinra vs placebo, on top of the standard of care, on restoration of myocardial function at 3 days following treatment initiation, in children admitted for acute myocarditis in intensive care units.
Epistemonikos ID: fbd6f3c0fd4e56cd06e39f307b45c12844982a1a
First added on: Jan 29, 2026